Background
End-stage renal disease (ESRD) is a growing public health problem with significant physiological, psychological and socio-economic implications for the individual, family and the community [
1,
2]. Despite advances in technology and medical care, it remains a serious and life-threatening illness with a very high mortality rate and low quality of life [
3‐
5]. Studies revealed the world wide incidence and prevalence of ESRD is increasing and it is projected that by 2020 the number of patients with ESRD will rise by nearly 60% in comparison with that of 2005 [
6,
7].
There are three treatment modalities for ESRD including hemodialysis, peritoneal dialysis, and transplant. Particularly, hemodialysis, one of the most extensively used renal replacement for patients with the disease [
8‐
11] imposes a great psychosocial burden on the patients due to the number of lifestyle, dietary, and fluid restrictions required to manage their disease [
1,
2].. However, evidence indicates that patients are frequently non adherent with prescribed medications and dietary and fluid recommendations causing ongoing challenges in the care of these patients [
1]. Moreover, these restrictions can impact a patient’s sense of personal control that can lead to disruptions in social relations and social withdrawal resulting in depression [
2,
12‐
14].
In patients with ESRD, adherence to dietary restrictions is significantly associated with improved patients’ outcomes while non adherence has a risk of complication leading to death [
15]. A study identified and grouped factors contributing to non-adherence as patient related, psychological, disease related, socioeconomic, therapy related and health care system related factors with their sub factors [
1]. For example, in one study satisfaction with social support, comorbidity and monthly family income were factors found to be associated with dietary and fluid adherence [
16]. However, others have reported discrepancies of results in studies that assessed the predictors of dietary non adherence in patients with ESRD receiving hemodialysis due primarily to the lack of a standardized method by the researchers for measuring non adherence [
17].
Extant research has found that depression is the most common mental comorbidity among ESRD patients [
12,
18,
19], although prevalence rates vary widely across studies ranging from 20% [
20] to 90% [
21]. Depressive symptoms also have been found to be associated with low adherence to prescribed dialysis treatments, including dietetic recommendations that may result in increased morbidity and mortality [
2]. Despite these findings, depression remains underdiagnosed and understudied in ESRD patients [
4,
22]. Depressive symptoms play a significant role in causing malnutrition that is closely related with morbidity, mortality, decrease in quality of life and delayed recovery in ESRD patients [
22]. However, studies have demonstrated inconsistent findings about the relationship between depressive symptoms and fluid and dietary adherence in patients with ESRD [
1]. In some studies, a negative relationship was established while in others no significant relationship was found. Therefore, the purpose of this paper is to review the prevalence of depressive symptoms and dietary non adherence in ESRD patients receiving hemodialysis and to provide a review of the quantitative research evidence regarding the relationship between depressive symptoms and dietary non adherence inpatients with ESRD receiving hemodialysis.
Discussions
Depressive symptoms
Even though depression is the prevalent mental illness in this review, findings from each included study demonstrated discrepancy. The reason for the large variation in prevalence across studies may be due to the diverse populations’ studied and different self-report instrument used to measure depression with no consistent cut point value employed in those studies. Similarly, the difficulty in defining depression has led to challenges in its measurement.
Most (72.7%) of the studies assessed depressive symptoms using self-report instruments and only three (27.3%) used both patient self-report and physician diagnosis. Among the latter, the prevalence of physician-diagnosed depression was 13.9%, which was approximately three times lower than the prevalence for patients using self-reported Center for Epidemiologic Studies Depression Scale (CES-D) score (43.0%) [
29]. Among those studies that applied patient self-report six (54.5%) used the Beck depression inventory (BDI), and the remaining five studies utilized a number of other self-report measures of depressive symptoms.
The BDI is considered to be the most commonly used and standard instrument for assessing symptoms of depression and the prevalence and severity of depression [
41,
42]. However, the use of this scale in ESRD of patients is challenging due to the somatic manifestation, included in the score that may be complicated by symptoms from uremia [
43]. It has been psychometrically tested and validated for ESRD patients [
44]. Additionally, the measure has been found to correlate highly with the diagnostic criteria for depression, quality of life, functional status and survival over time [
45]. A variety of other measures were used to assess depressive symptoms in ESRD patients receiving hemodialysis. One study employed the CES-D scale to determine the prevalence of depression in ESRD patients [
24]. Even though there is a lack of studies on the validity of CES-D in this population, it has been validated against the Beck Depression Inventory and shown to have predictive power for clinical outcomes in patients with other diseases [
46,
47].
Studies also used measures including the Hospital Anxiety and Depression Scale (HADS) and Geriatric Depression Scale (GDS) [
23,
30]. The application of diverse instruments in these studies delivered challenges for researchers to compare findings across studies and populations, which may influence global conclusions about the prevalence of depressive symptoms in ESRD patients.
Inconsistent result was found about factors affecting depressive symptoms. This may be related to small sample sizes, patient characteristics [
24,
27] and diverse countries with different cultures represented across those studies [
16]. Generally, both the prevalence and factors associated with depressive symptoms showed inconsistency in these studies. In addition, the variability of screening methods for depressive symptoms made the comparison between studies challenging.
Dietary non adherence
The prevalence of dietary non-adherence is again inconsistence. Inconsistent prevalence-rates across these studies may be the result of biological measures being affected by many factors including residual renal function, dialysis adequacy, time at which blood was obtained for the analysis between dialysis, acid-base balance, and adherence with medication [
48]. Furthermore, the large variation in estimates using self-reported instruments was possibly caused by the lack of generally accepted and validated gold standard measure of adherence [
39].
Six (60%) out of the ten studies employed the Dialysis Diet and Fluid Non-Adherence Questionnaire (DDFQ) [
31‐
35,
39] while two studies utilized self-report measures other than DDFQ [
36,
39]. The DDFQ was designed to measure non-adherence behavior with diet and fluid in ESRD patients having hemodialysis with established content validity in the last 14 days. Moreover, its validity could be supported by using biological measures including serum potassium, phosphorus, and BUN levels [
39]. Concerning the internal consistency of DDFQ, a Cronbach’s alpha of 0.81 was reported when the measure was used with patients receiving hemodialysis [
31]. Studies demonstrated that DDFQ is weakly but positively correlated with biomedical indicators of adherence, such as inter-dialytic weight gain [
31,
39] whereas another study revealed no significant correlations between any of the biochemical measures of dietary adherence and self-reported dietary adherence [
39].
Overall, variables such as young age, social support, educational status, behavioral control and positive attitudes were identified as factors significantly associated with dietary non adherence in ESRD patients receiving hemodialysis. In general, studies demonstrated diverse results in both the prevalence of dietary non adherence and in its related risk factors.
Depressive symptoms and dietary non adherence
Although majority of the studies reported a negative association between depressive symptoms/depression and dietary adherence, there is still a report of no association. The inconsistent findings may be related to the use of different instruments, some studies used the Dialysis Diet and Fluid non adherence Questionnaire (DDFQ) self-reports measure [
18] and others employed different biomarkers to assess dietary non adherence in these studies. For example, one study measured blood urea nitrogen (BUN), serum creatinine, potassium, and phosphate levels [
49] whereas others assessed serum albumin and protein catabolic rate [
20,
40,
50] as indicators of dietary non adherence. Additional issues include: different characteristics of the study samples, the use of small and convenient sampling and inclusion of a wide range of countries with different cultures. Although, these issues make study comparison more difficult, most of these researchers concluded that having depressive symptoms was associated with increased dietary non adherence. However, without considering this issues and without uniformly applying standardized criteria, establishing a causal relationship between depressive symptoms and dietary non adherence remains difficult. Moreover, since all studies included in this review are cross-sectional, the lack of temporal ordering to test if depression leads to dietary non adherence or depression results from dietary non adherence is a weakness.
Conclusions
In conclusion, despite the variation in assessment tool applied, depressive symptoms and dietary non adherence were highly prevalent in patients with ESRD receiving hemodialysis therapy. Nearly all of the articles that examined the relationship between depressive symptoms and dietary non adherence showed significant associations. Therefore, it is possible to recommend that early diagnosis and treatment of depression and close monitoring of adherence behavior are especially important in ESRD patients to improve their quality of life. Moreover, it will be important to consider both pharmacological and non-pharmacological (e.g. social support) interventions to reduce depression in order to enhance adherence and improve survival rates. This review brought up a clear association between depressive symptoms and dietary non-adherence which enable health care providers, specifically, nurses working in nephrology unit and related areas to monitor and improve patients QOL by providing appropriate interventions. Since this review included cross sectional studies, a causal relationship between depressive symptoms and dietary non adherence among ESRD patients receiving hemodialysis cannot be determined at this time. Future research (experimental or cohort studies) using gold standard measures with established cut-points is needed to further define this relationship and explores appropriate interventions. Moreover, as this review included only quantitative studies and searched limited databases, some studies might not be included in the review.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.